DB31795ExperimentalSmall molecule
FRAX716 is a group I-specific p21-activated kinase (PAK) inhibitor which dramatically inhibits the phosphorylation of PAK and Mek1.
- Mechanism
- Curator reviewed · 2 references
FRAX716 selectively inhibits the group I p21-activated kinases (PAKs) which includes PAK1, PAK2, and PAK3.
- Code names
- FRAX716
Resolves to
Compound
What you can answer from here — as of December 04, 2025
3Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with FRAX716, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account